Search
for
Sort by
Research 931–960 of 1000+
- Delphi Consensus on Attenuated Androgen Use for Long‐Term Prophylaxis in Hereditary Angioedema: AURA Project
- Mineral Deficiencies: A Root Cause for Reduced Longevity in Mammals
- Prevalence and Patterns of Dermatological Diseases in Lesbian, Gay, Bisexual, Transgender, and Queer Population: A Cross-Sectional Survey
- Case Report:Pregnancy and birth in a mild phenotype of Alström syndrome
- Suspected adverse reactions to medications and food supplements containing <i>Serenoa repens</i>: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports
- Premium Doctors’ Approach to Aesthetic Treatments for Men: Trends and Clinical Outcomes
- Disturbance of the Circadian System in Shift Work and Its Health Impact
- Eco-innovation in action: valorizing vegetable waste into high-value ingredients for sustainable applications
- Nanomaterials in hair care and treatment
- Fetal alpha 5-reductase Val89Leu mutation is associated with late miscarriage
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Activator Protein-1 Activity Regulates Epithelial Tumor Cell Identity
- Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment
- Retrospective evaluation of Penguin Cold Caps for chemotherapy-induced alopecia
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- Post-finasteride syndrome – does it really exist?
- Role of the Wnt signaling pathway in keratoacanthoma
- Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened
- Genetic analysis of a novel antioxidant multi-target iron chelator, M30 protecting against chemotherapy-induced alopecia in mice
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Preclinical Development and Phase I Study of ZSYY001, a Polymeric Micellar Paclitaxel for Advanced Solid Tumor
- Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping
- Antiandrogen therapy for androgenetic alopecia
- QSAR Analysis of a Series of Hydantoin‐based Androgen Receptor Modulators and Corresponding Binding Affinities
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation
- Screening for diabetes in women with polycystic ovary syndrome
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Acne